Simplex Trading, LLC Biomarin Pharmaceutical Inc Transaction History

Simplex Trading, LLC

$2.98 Billion
Q2 2024

A detailed history of Simplex Trading, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Simplex Trading, LLC holds 8,351 shares of BMRN stock, worth $586,574. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,351

Previous 17,638 52.65%

Holding current value

$586,574

Previous $1.54 Million 55.39%

% of portfolio

0.02%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$74.43 - $92.22 $691,231 - $856,447	-9,287 Reduced 52.65%	8,351 $687,000
Q1 2024 Apr 25, 2024	SELL	$83.81 - $99.0 $910,595 - $1.08 Million	-10,865 Reduced 38.12%	17,638 $1.54 Million
Q4 2023 Feb 02, 2024	BUY	$76.22 - $98.51 $2.17 Million - $2.81 Million	28,503 New	28,503 $2.75 Million
Q1 2023 Apr 27, 2023	BUY	$87.74 - $117.27 $846,866 - $1.13 Million	9,652 New	9,652 $938,000
Q3 2022 Nov 04, 2022	SELL	$82.16 - $96.94 $196,937 - $232,365	-2,397 Reduced 21.36%	8,825 $748,000
Q2 2022 Aug 03, 2022	BUY	$71.48 - $86.85 $20,014 - $24,318	280 Added 2.56%	11,222 $929,000
Q1 2022 May 02, 2022	SELL	$74.28 - $92.69 $1.15 Million - $1.44 Million	-15,523 Reduced 58.65%	10,942 $843,000
Q4 2021 Feb 23, 2022	BUY	$71.72 - $91.47 $1.01 Million - $1.29 Million	14,151 Added 114.92%	26,465 $2.34 Million
Q3 2021 Oct 28, 2021	SELL	$74.77 - $85.47 $270,218 - $308,888	-3,614 Reduced 22.69%	12,314 $1.03 Million
Q2 2021 Aug 12, 2021	SELL	$75.51 - $84.79 $498,063 - $559,274	-6,596 Reduced 29.28%	15,928 $1.33 Million
Q1 2021 Apr 26, 2021	BUY	$74.73 - $90.69 $1.68 Million - $2.03 Million	22,424 Added 22424.0%	22,524 $1.7 Million
Q4 2020 Feb 02, 2021	SELL	$72.61 - $90.2 $2.61 Million - $3.24 Million	-35,899 Reduced 99.72%	100 $8,000
Q3 2020 Oct 14, 2020	BUY	$71.87 - $131.03 $772,530 - $1.41 Million	10,749 Added 42.57%	35,999 $2.74 Million
Q2 2020 Jul 13, 2020	BUY	$79.55 - $124.22 $379,692 - $592,902	4,773 Added 23.31%	25,250 $3.11 Million
Q1 2020 Apr 29, 2020	BUY	$71.37 - $96.85 $386,397 - $524,345	5,414 Added 35.94%	20,477 $1.73 Million
Q4 2019 Feb 05, 2020	BUY	$64.27 - $86.37 $494,107 - $664,012	7,688 Added 104.24%	15,063 $1.27 Million
Q3 2019 Oct 15, 2019	BUY	$67.4 - $85.11 $497,075 - $627,686	7,375 New	7,375 $497,000
Q2 2019 Jul 26, 2019	SELL	$80.35 - $93.9 $405,847 - $474,288	-5,051 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$84.2 - $98.62 $32,080 - $37,574	381 Added 8.16%	5,051 $0
Q4 2018 Jan 16, 2019	SELL	$80.14 - $106.07 $364,877 - $482,936	-4,553 Reduced 49.37%	4,670 $397,000
Q3 2018 Oct 23, 2018	BUY	$93.92 - $105.72 $204,276 - $229,941	2,175 Added 30.86%	9,223 $894,000
Q2 2018 Jul 30, 2018	BUY	$76.01 - $99.03 $67,116 - $87,443	883 Added 14.32%	7,048 $663,000
Q1 2018 Apr 26, 2018	SELL	$77.67 - $92.63 $412,971 - $492,513	-5,317 Reduced 46.31%	6,165 $499,000
Q4 2017 Jan 10, 2018	BUY	$80.76 - $95.13 $927,286 - $1.09 Million	11,482	11,482 $1.02 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Biomarin Pharmaceutical Inc Transaction History